Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass.
暂无分享,去创建一个
B. McCrindle | G. V. van Arsdell | C. Manlhiot | R. Richards | Anthony K. C. Chan | C. Foreman | H. Holtby | Lynn Crawford-Lean | C. Gruenwald | H. Moriarty
[1] B. McCrindle,et al. Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery. , 2010, The journal of extra-corporeal technology.
[2] P. Fallon,et al. Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation. , 2009, Blood.
[3] F. Szlam,et al. A Comparison of Heparin Management Strategies in Infants Undergoing Cardiopulmonary Bypass , 2008, Anesthesia and analgesia.
[4] P. Monagle,et al. Developmental haemostasis , 2006, Thrombosis and Haemostasis.
[5] F. Szlam,et al. An Evaluation of the Effects of a Standard Heparin Dose on Thrombin Inhibition During Cardiopulmonary Bypass in Neonates , 2005, Anesthesia and analgesia.
[6] B. Giroir,et al. Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants. , 2004, The New England journal of medicine.
[7] M. Appelblad,et al. Measurement of the activated clotting time during cardiopulmonary bypass: differences between Hemotec® ACT and Hemochron® Jr apparatus , 2004, Perfusion.
[8] W. Kuebler,et al. Heparin-Level-Based Anticoagulation Management During Cardiopulmonary Bypass: A Pilot Investigation on the Effects of a Half-Dose Aprotinin Protocol on Postoperative Blood Loss and Hemostatic Activation and Inflammatory Response , 2004, Anesthesia and analgesia.
[9] Nancy E. Marsh,et al. Heparin monitoring during cardiac surgery. Part 2: calculating the overestimation of heparin by the activated clotting time , 2003, Perfusion.
[10] M. Ray,et al. Heparin monitoring during cardiac surgery. Part 1: validation of whole-blood heparin concentration and activated clotting time , 2003, Perfusion.
[11] R. Hetzer,et al. Hemostatic Activation and Inflammatory Response during Cardiopulmonary Bypass: Impact of Heparin Management , 2002, Anesthesiology.
[12] G. von Bernuth,et al. Cytokine balance in infants undergoing cardiac operation. , 2002, The Annals of thoracic surgery.
[13] C. Ludlam,et al. Individualized heparin and protamine management in infants and children undergoing cardiac operations. , 2001, The Annals of thoracic surgery.
[14] G. Gravlee,et al. Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. , 1999, Anesthesiology.
[15] J. Jaggers,et al. Infant cardiopulmonary bypass: a procoagulant state. , 1999, The Annals of thoracic surgery.
[16] S. Bratton,et al. Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery. , 1999, Anesthesia and analgesia.
[17] M. Elliott. Modified ultrafiltration and open heart surgery in children , 1999, Paediatric anaesthesia.
[18] S. Bratton,et al. Association between age and blood loss in children undergoing open heart operations. , 1998, The Annals of thoracic surgery.
[19] G. Despotis,et al. A comparison between continuous infusion versus standard bolus administration of heparin based on monitoring in cardiac surgery , 1997, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[20] W. Williams,et al. Coagulation and Fibrinolytic Profile of Paediatric Patients Undergoing Cardiopulmonary Bypass , 1997, Thrombosis and Haemostasis.
[21] E. Spitznagel,et al. More Effective Suppression of Hemostatic System Activation in Patients Undergoing Cardiac Surgery by Heparin Dosing Based on Heparin Blood Concentrations rather than ACT , 1996, Thrombosis and Haemostasis.
[22] G. Rivard,et al. Mediastinal bleeding after cardiopulmonary bypass in pediatric patients. , 1996, The Annals of thoracic surgery.
[23] J. Shayevitz,et al. Age-related differences in heparin sensitivity and heparin-protamine interactions in cardiac surgery patients. , 1996, Journal of cardiothoracic and vascular anesthesia.
[24] G. Despotis,et al. Aprotinin Prolongs Activated and Nonactivated Whole Blood Clotting Time and Potentiates the Effect of Heparin In Vitro , 1996, Anesthesia and analgesia.
[25] C. Greenberg,et al. Characterization of Prothrombin Activation during Cardiac Surgery by Hemostatic Molecular Markers , 1994, Anesthesiology.
[26] W. Williams,et al. Thrombin regulation in congenital heart disease after cardiopulmonary bypass operations. , 1994, The Journal of thoracic and cardiovascular surgery.
[27] V. Olshove,et al. Heparin dose response in pediatric cardiopulmonary bypass , 1994 .
[28] W. Williams,et al. Heparin Therapy during Cardiopulmonary Bypass in Children Requires Ongoing Quality Control , 1993, Thrombosis and Haemostasis.
[29] H. Philippou,et al. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. , 1993, Blood.
[30] F. Ofosu,et al. Maturation of the hemostatic system during childhood. , 1992, Blood.
[31] P. Hickey,et al. Coagulation defects in neonates during cardiopulmonary bypass. , 1992, The Annals of thoracic surgery.
[32] Carolyn H. Fotouhi,et al. Comparison study of the Hepcon System Four and the Hemostasis Management System , 1991, Perfusion.
[33] C. Lake. Pediatric Cardiac Anesthesia , 1988 .
[34] P. Powers,et al. Development of the human coagulation system in the full-term infant. , 1987, Blood.
[35] F. Spencer,et al. Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass. , 1981, Annals of surgery.
[36] D. Benson,et al. Control of heparin therapy in open-heart surgery. , 1974, The Journal of thoracic and cardiovascular surgery.
[37] S. Epstein,et al. Statistical correlation and heparin sensitivity of activated partial thromboplastin time, whole blood coagulation time, and an automated coagulation time. , 1973, American journal of clinical pathology.
[38] E. B. Tuohy. Progress in anesthesiology. , 1950, Postgraduate medicine.